These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35967876)

  • 21. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
    Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
    PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervicovaginal Microbiota and Reproductive Health: The Virtue of Simplicity.
    Anahtar MN; Gootenberg DB; Mitchell CM; Kwon DS
    Cell Host Microbe; 2018 Feb; 23(2):159-168. PubMed ID: 29447695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in understanding of multifaceted changes in the vaginal microenvironment: implications in vaginal health and therapeutics.
    Das S; Bhattacharjee MJ; Mukherjee AK; Khan MR
    Crit Rev Microbiol; 2023 Mar; 49(2):256-282. PubMed ID: 35312419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens.
    Kaewsrichan J; Peeyananjarassri K; Kongprasertkit J
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):75-83. PubMed ID: 16965354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
    Matu MN; Orinda GO; Njagi EN; Cohen CR; Bukusi EA
    Anaerobe; 2010 Jun; 16(3):210-5. PubMed ID: 19925874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterisation of vaginal lactobacilli from South African women.
    Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H
    BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The right bug in the right place: opportunities for bacterial vaginosis treatment.
    Wu S; Hugerth LW; Schuppe-Koistinen I; Du J
    NPJ Biofilms Microbiomes; 2022 May; 8(1):34. PubMed ID: 35501321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.
    Ling Z; Liu X; Chen W; Luo Y; Yuan L; Xia Y; Nelson KE; Huang S; Zhang S; Wang Y; Yuan J; Li L; Xiang C
    Microb Ecol; 2013 Apr; 65(3):773-80. PubMed ID: 23250116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis.
    Mitchell C; Fredricks D; Agnew K; Hitti J
    Sex Transm Dis; 2015 Jul; 42(7):358-63. PubMed ID: 26222747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hydrogen peroxide-producing Lactobacillus species in healthy women and in women with bacterial vaginosis].
    Shopova E
    Akush Ginekol (Sofiia); 2003; 42 Suppl 1():12-5. PubMed ID: 12858496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.
    Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR
    Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial Vaginosis: Effects on reproduction and its therapeutics.
    Ding C; Yu Y; Zhou Q
    J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102174. PubMed ID: 34087449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis.
    Pybus V; Onderdonk AB
    Microbes Infect; 1999 Apr; 1(4):285-92. PubMed ID: 10602662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study.
    Vasundhara D; Raju VN; Hemalatha R; Nagpal R; Kumar M
    Indian J Med Res; 2021 Apr; 153(4):492-502. PubMed ID: 34380796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial vaginosis: a review on clinical trials with probiotics.
    Mastromarino P; Vitali B; Mosca L
    New Microbiol; 2013 Jul; 36(3):229-38. PubMed ID: 23912864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Two-Way Interaction between the Molecules That Cause Vaginal Malodour and Lactobacilli: An Opportunity for Probiotics.
    Puebla-Barragan S; Akouris PP; Al KF; Carr C; Lamb B; Sumarah M; van der Veer C; Kort R; Burton J; Reid G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
    Abad CL; Safdar N
    J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Lactofem Oral Probiotic Capsule on Lactobacilli Colonization and Some Vaginal Health Parameters.
    Balaghi Z; Azima S; Motamedifar M; Kaviani M; Poordast T; Zare N
    Gynecol Obstet Invest; 2020; 85(3):245-251. PubMed ID: 32252049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [GynOphilus--a winning relay].
    Kovachev S
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():41-4. PubMed ID: 23236678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.